BioInvent International AB (publ) (STO:BINV)
Sweden
· Delayed Price · Currency is SEK 22.25
-0.45 (-1.98%)
Mar 9, 2026, 5:29 PM CET
STO:BINV Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 226.5 | 44.69 | 71.46 | 326.13 | 19.38 | Upgrade
|
| Revenue Growth (YoY) | 406.86% | -37.47% | -78.09% | 1582.45% | -86.85% | Upgrade
|
| Gross Profit | 226.5 | 44.69 | 71.46 | 326.13 | 19.38 | Upgrade
|
| Selling, General & Admin | 73.67 | 58.3 | 51.61 | 50.75 | 39.44 | Upgrade
|
| Research & Development | 504.22 | 457.73 | 390.43 | 325.93 | 258.34 | Upgrade
|
| Other Operating Expenses | 0.29 | -0.1 | -0.02 | -0.08 | -0.23 | Upgrade
|
| Operating Expenses | 578.18 | 515.93 | 442.02 | 376.6 | 297.55 | Upgrade
|
| Operating Income | -351.68 | -471.25 | -370.56 | -50.47 | -278.17 | Upgrade
|
| Interest Expense | - | -0.56 | -0.64 | -0.65 | -0.52 | Upgrade
|
| Interest & Investment Income | 19.22 | 42.09 | 40.61 | 9.07 | 0.26 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.47 | 0.49 | -0.45 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -332.46 | -429.24 | -330.1 | -42.5 | -278.44 | Upgrade
|
| Pretax Income | -332.46 | -429.24 | -330.1 | -42.5 | -278.44 | Upgrade
|
| Income Tax Expense | 0.4 | 0.14 | 0.2 | - | - | Upgrade
|
| Net Income | -332.86 | -429.38 | -330.3 | -42.5 | -278.44 | Upgrade
|
| Net Income to Common | -332.86 | -429.38 | -330.3 | -42.5 | -278.44 | Upgrade
|
| Shares Outstanding (Basic) | 66 | 66 | 66 | 62 | 54 | Upgrade
|
| Shares Outstanding (Diluted) | 66 | 66 | 66 | 62 | 54 | Upgrade
|
| Shares Change (YoY) | -0.03% | 0.06% | 6.90% | 13.59% | 88.61% | Upgrade
|
| EPS (Basic) | -5.06 | -6.53 | -5.02 | -0.69 | -5.14 | Upgrade
|
| EPS (Diluted) | -5.06 | -6.53 | -5.02 | -0.69 | -5.14 | Upgrade
|
| Free Cash Flow | -255.02 | -390.5 | -355 | -53.6 | -259.1 | Upgrade
|
| Free Cash Flow Per Share | -3.88 | -5.93 | -5.40 | -0.87 | -4.78 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -155.27% | -1054.58% | -518.54% | -15.48% | -1435.02% | Upgrade
|
| Profit Margin | -146.96% | -960.87% | -462.22% | -13.03% | -1436.46% | Upgrade
|
| Free Cash Flow Margin | -112.59% | -873.88% | -496.77% | -16.44% | -1336.68% | Upgrade
|
| EBITDA | -331.81 | -460.01 | -361.29 | -41.91 | -269.79 | Upgrade
|
| EBITDA Margin | -146.50% | - | - | -12.85% | - | Upgrade
|
| D&A For EBITDA | 19.87 | 11.24 | 9.26 | 8.56 | 8.37 | Upgrade
|
| EBIT | -351.68 | -471.25 | -370.56 | -50.47 | -278.17 | Upgrade
|
| EBIT Margin | -155.27% | - | - | -15.48% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.